BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18320146)

  • 41. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 8. Asymptomatic hyperuricemia].
    Hosoya T; Ohno I
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):882-9. PubMed ID: 23772502
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical Significance of Serum Uric Acid Levels in Mexican Young Adults.
    Alegría-Díaz A; Valdez-Ortiz R; Murguía-Romero M; Jiménez-Flores R; Villalobos-Molina R; Mummidi S; Duggirala R; López-Alvarenga JC; Pérez-Navarro M
    Contrib Nephrol; 2018; 192():125-134. PubMed ID: 29393152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between hyperuricemia and chronic kidney disease.
    Ohno I
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1039-44. PubMed ID: 22132954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu.
    Huang G; Xu J; Zhang T; Cai L; Liu H; Yu X; Wu J
    Sci Rep; 2020 May; 10(1):8678. PubMed ID: 32457306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uric acid and hypertension: a focused review and practical recommendations.
    De Becker B; Borghi C; Burnier M; van de Borne P
    J Hypertens; 2019 May; 37(5):878-883. PubMed ID: 30620339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.
    Yoo TW; Sung KC; Shin HS; Kim BJ; Kim BS; Kang JH; Lee MH; Park JR; Kim H; Rhee EJ; Lee WY; Kim SW; Ryu SH; Keum DG
    Circ J; 2005 Aug; 69(8):928-33. PubMed ID: 16041161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uric acid and hypertension.
    Schachter M
    Curr Pharm Des; 2005; 11(32):4139-43. PubMed ID: 16375735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F; Leoncini G; Pontremoli R
    Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension.
    Campo C; Ruilope LM; Segura J; Rodicio JL; García-Robles R; Garcia-Puig J
    Blood Press; 2003; 12(5-6):277-83. PubMed ID: 14763658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
    Johnson RJ; Kang DH; Feig D; Kivlighn S; Kanellis J; Watanabe S; Tuttle KR; Rodriguez-Iturbe B; Herrera-Acosta J; Mazzali M
    Hypertension; 2003 Jun; 41(6):1183-90. PubMed ID: 12707287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A role for uric acid in the progression of renal disease.
    Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: Pathologic implications and putative pharmacologic targets.
    Balakumar P; Alqahtani A; Khan NA; Mahadevan N; Dhanaraj SA
    Pharmacol Res; 2020 Nov; 161():105209. PubMed ID: 32979505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum uric acid levels and risk of metabolic syndrome in healthy adults.
    Ebrahimpour P; Fakhrzadeh H; Heshmat R; Bandarian F; Larijani B
    Endocr Pract; 2008 Apr; 14(3):298-304. PubMed ID: 18463036
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uric acid and transplantation.
    Mazali FC; Mazzali M
    Semin Nephrol; 2011 Sep; 31(5):466-71. PubMed ID: 22000655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age.
    Russo E; Leoncini G; Esposito P; Garibotto G; Pontremoli R; Viazzi F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia.
    Reungjui S; Pratipanawatr T; Johnson RJ; Nakagawa T
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):470-6. PubMed ID: 18695387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Uric acid as a risk factor for cardiovascular diseases].
    Cibičková Ľ; Karásek D
    Vnitr Lek; 2016; 62(11):919-923. PubMed ID: 28128580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement.
    Hu QH; Wang C; Li JM; Zhang DM; Kong LD
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1080-91. PubMed ID: 19605544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.